According to a market report by Lucintel, the future of the global head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets. The global head and neck cancer diagnostic market is expected to reach an estimated $7,357 million by 2035 with a CAGR of 8.5% from 2026 to 2035. The major drivers for this market are the increasing use of molecular & genetic testing, the growing demand for accurate & faster diagnosis, and the rising awareness about early cancer detection benefits.
A more than 150-page report to understand trends, opportunity and forecast in head and neck cancer diagnostic market to 2035 by type (laryngeal cancer, pharyngeal cancer, salivary gland cancer, lip & oral cavity cancer, nasopharyngeal cancer, and others), treatment (chemotherapy, radiation therapy, targeted therapy, surgery, and others), diagnosis (biopsy, blood tests, dental diagnosis, imaging, and endoscopy), end use (hospitals, ambulatory surgical centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, lip & oral cavity cancer is expected to witness the highest growth over the forecast period.
Within the end use category, hospital is expected to witness the highest growth.
Download sample by clicking on head and neck cancer diagnostic market
In terms of region, APAC is expected to witness the highest growth over the forecast period.
GE Healthcare, Philips, Siemens Healthineers, Merck, Eli Lilly are the major suppliers in the head and neck cancer diagnostic market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] to get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Reference Check Software Market
PSA Hydrogen Purification Market
Poly (P-phenylene Terephthalamide) Market
Point-of-Entry Water Purifier Market
Plastic Pre-Filled Syringe Market